WHO Global Health Estimates. Deaths by Cause, Age, Sex, by Country and by region, 2000–2016. Geneva: World Health Organization; 2016.

Google Scholar 

https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html (accessed 8.8.2022).

IDF Diabetes Atlas. 9th ed: International Diabetes Federation; 2019. https://www.diabetesatlas.org (accessed 8.8.2022).

WHO Diabetes Fact Sheet. World Health Organization 2018 https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed 8.8.2022).

Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, et al. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39(3):472–80.

Article  CAS  PubMed  Google Scholar 

Joshi SR, Parikh RM. India–diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323–4.

PubMed  Google Scholar 

Tubak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high risk state for diabetes development. Lancet Diabetes. 2012;379(9833):2279–90.

Article  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. https://doi.org/10.2337/dc23-S002. Erratum in: Diabetes Care. 2023 Feb 01;: Erratum in: Diabetes Care. 2023 Sep 1;46(9):1715. PMID: 36507649; PMCID: PMC9810477.

Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33(2):442–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014;7:587–91.

Article  PubMed  PubMed Central  Google Scholar 

Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444–70.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization Fact Sheet Cardiovascular Disease 2017. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 8.8.2022).

Bergman M, Buysschaert M, Schwarz PE, et al. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.

Article  CAS  PubMed  Google Scholar 

Dassanayake AS, Kasthuriratne A, Rindrajith S, et al. prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24:1284–8.

Article  PubMed  Google Scholar 

De Silva ST, Niriella MA, Ediriweera DS, et al. Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. Diabetol Metab Syndr. 2019;11:66.

Article  PubMed  PubMed Central  Google Scholar 

Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diab Med. 2010;27(6):636–43.

Article  CAS  Google Scholar 

Niriella MA, Pathmeswaran A, De Silva ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. Liver Int. 2017;37:1715–22.

Article  CAS  PubMed  Google Scholar 

Wang C, Li J, Xue H, et al. Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. 2015;107(3):424–32.

Article  PubMed  Google Scholar 

Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–64.

Article  PubMed  PubMed Central  Google Scholar 

Grønbaek H, Thomsen KL, Rungby J, et al. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol. 2008;2:705–11.

Article  PubMed  Google Scholar 

Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27–38.

Article  CAS  PubMed  Google Scholar 

Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med. 2008;25:476–781.

Article  CAS  PubMed  Google Scholar 

Kasturiratne A, Weerasinghe S, Dassanayake A, et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J of Gastroenterol and Hepatol. 2013;28:142–7.

Article  Google Scholar 

Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936–44. https://doi.org/10.1111/jgh.13264. (PMID: 26667191).

Article  CAS  PubMed  Google Scholar 

Fuster JJ, Ouchi N, Gokce N, et al. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016;118(11):1786–807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam BC, Koh GC, Chen C, et al. Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE. 2015;10(4): e0122985.

Article  PubMed  PubMed Central  Google Scholar 

Jung SH, Ha KH, Kim DJ. Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults. Yonsei Med J. 2016;57(3):674–80.

Article  PubMed  PubMed Central  Google Scholar 

Garber A, Handelsman Y, Einhorn D, et al. Diagnosis and management of pre-diabetes in the continuum of hyperglycemia – When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933–46.

Article  PubMed  Google Scholar 

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38:S10.

Google Scholar 

Herman WH. The economic costs of diabetes: Is it time for a new treatment paradigm? Diabetes Care. 2013;36:775–6.

Article  PubMed  PubMed Central  Google Scholar 

Icks A, Haastert B, Gandjour A, et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: The KORA Survey 2000. Diabetes Care. 2004;27:2120–8.

Article  PubMed  Google Scholar 

Perreault L, Pan Q, Mather KJ, et al. Effect of regression from pre-diabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004;12(9):1426–34. https://doi.org/10.1038/oby.2004.179.

Article  PubMed  Google Scholar 

WHO Global report on diabetes. World Health Organization. 2016 https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=819FEED04CAF00A8AA00C30165979E93?sequence=1 (accessed 8.8.2022).